Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

AMRI and Navigen enter into research collaboration

April 20, 2010

Cyplasin signs term sheet with vaccine company to license AAD technology

April 16, 2010

Metabolex and Takeda enter research collaboration for biological products

April 15, 2010

RXi and miRagen to collaborate on miRNA-based agents

April 15, 2010

RXi and Mirna Therapeutics form microRNA research collaboration

April 14, 2010

Arecor and Genzyme join to develop advanced therapeutic protein formulations

April 14, 2010

MaxCyte and Medinet expand license agreement for cell loading technology

April 13, 2010

Nonselective inhibitor pandacostat discovered by chemical phylogenetic analysis of HDACs

April 13, 2010

Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20

April 8, 2010

GSK and Isis to develop RNA-targeted therapeutics for rare and infectious diseases

April 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...